Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolution of Orexin Neuropeptide System: Structure and Function
Shingo Soya, Takeshi Sakurai
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
Alcohol use disorders and ADHD
Mathias Luderer, Josep Antoni Ramos‐Quiroga, Stephen V. Faraone, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 128, pp. 648-660
Closed Access | Times Cited: 63
Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist
Angela Glen, Roland W. Bürli, David G. Livermore, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 100, pp. 129629-129629
Open Access | Times Cited: 8
Modulation of noradrenergic signalling reverses stress-induced changes in the hippocampus: Involvement of orexinergic systems
Masoumeh Sarfi, Mahmoud Elahdadi Salmani, Taghi Lashkarbolouki, et al.
Brain Research (2025), pp. 149491-149491
Open Access | Times Cited: 1
Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
Catherine Roch, Giorgio Bergamini, Michel A. Steiner, et al.
Psychopharmacology (2021) Vol. 238, Iss. 10, pp. 2693-2708
Open Access | Times Cited: 50
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases
Yu Sun, Ryan K. Tisdale, Thomas S. Kilduff
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 22-37
Open Access | Times Cited: 42
Orexin receptors 1 and 2 in serotonergic neurons differentially regulate peripheral glucose metabolism in obesity
Xing Xiao, Gagik Yeghiazaryan, Simon Heß, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 41
Physiological Role of Orexinergic System for Health
Ines Villano, Marco La Marra, Girolamo Di Maio, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8353-8353
Open Access | Times Cited: 33
Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone
Martin A. Katzman, Matthew P. Katzman
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 150-150
Open Access | Times Cited: 30
Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy
Mohammad Sheibani, Maryam Shayan, Mina Khalilzadeh, et al.
Neuropeptides (2023) Vol. 99, pp. 102335-102335
Closed Access | Times Cited: 18
The Mechanism of the Gut-Brain Axis in Regulating Food Intake
Shouren Li, Mengqi Liu, Shixi Cao, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3728-3728
Open Access | Times Cited: 18
Phoenixin: More than Reproductive Peptide
Maria Billert, Agnieszka Rak, Krzysztof W. Nowak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8378-8378
Open Access | Times Cited: 47
Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 26
Orexinergic innervations at GABAergic neurons of the lateral habenula mediates the anesthetic potency of sevoflurane
Fang Zhou, Dan Wang, Huiming Li, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 5, pp. 1332-1344
Open Access | Times Cited: 15
Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease
J Kron, Ryan J. Keenan, Daniël Hoyer, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 359-386
Open Access | Times Cited: 15
A review of physiological functions of orexin: From instinctive responses to subjective cognition
LiBo Xia, Haiyan Liu, Bi Yan Wang, et al.
Medicine (2023) Vol. 102, Iss. 26, pp. e34206-e34206
Open Access | Times Cited: 14
Deficiency of Orexin Receptor Type 1 in Dopaminergic Neurons Increases Novelty-Induced Locomotion and Exploration
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
(2025)
Open Access
Dopamine Drives Feedforward Inhibition to Orexin Feeding System, Mediating Weight Loss Induced by Morphine Addiction
Huiming Li, Sa Wang, Dan Wang, et al.
Advanced Science (2025)
Open Access
Deficiency of orexin receptor type 1 in dopaminergic neurons increases novelty-induced locomotion and exploration
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
eLife (2025) Vol. 12
Open Access
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Orexin/hypocretin receptor 2 signaling in MCH neurons regulates REM sleep and insulin sensitivity
Shuntaro Izawa, Debora Fuscà, Hong Jiang, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115277-115277
Open Access
The Involvement of Brain Norepinephrine Nuclei in Eating Disorders
Carla L. Busceti, Gloria Lazzeri, Francesca Biagioni, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106069-106069
Closed Access
The Complexly Parcellated, Yet Quantitatively Reduced, Orexinergic/Hypocretinergic System of Humans
Illke B. Malungo, Ayanda Ngwenya, Mads F. Bertelsen, et al.
The Journal of Comparative Neurology (2025) Vol. 533, Iss. 2
Open Access
Orexin receptors: possible therapeutic targets for psychiatric disorders
Shigeyuki Chaki
Psychopharmacology (2025)
Closed Access
The role of the hypothalamus in the development of cancer cachexia
Dimitrios Stagikas, Yannis V. Simos, Λάμπρος Λάκκας, et al.
Physiology & Behavior (2025), pp. 114909-114909
Closed Access
Page 1 - Next Page

Scroll to top